Financial Instruments (Tables)

3 Months Ended

Apr. 03, 2021

Notes To Financial Statements [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following table summarizes the company’s fair value of interest rate swaps (in thousands):

	Condensed Consolidated Balance Sheet Presentation	Apr 3, 2021		Jan 2, 2021
Fair value	Other assets	$	3,014	$	—
Fair value	Accrued expenses	$	10,672	$	14,075
Fair value	Other non-current liabilities	$	26,696	$	37,018

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

The impact on earnings from interest rate swaps was as follows (in thousands):

		Three Months Ended
	Presentation of Gain/(loss)	Apr 3, 2021		Mar 28, 2020
Gain/(loss) recognized in accumulated other comprehensive income	Other comprehensive income	$	11,716	$	(35,785)
Gain/(loss) reclassified from accumulated other comprehensive income (effective portion)	Interest expense	$	(5,023)	$	(1,267)